Takeda-backed Ascentage Pharma aims to raise $126 million in US IPO
Ascentage Pharma said on Thursday it aims to raise $126.4 million in an initial public offering in the United States, becoming the first sizeable Chinese firm to seek a listing in the U.S. this year.
Venture Global LNG Raises $1.75 Billion After Pricing US IPO
(Reuters) -Venture Global LNG has raised $1.75 billion after pricing its U.S. initial public offering within range, the ...